The firm's software platform, coupled with a robust QMS, reduces barriers to entry for companies seeking to develop SaMD and connected device applications.
Company's multiplexed platform pairs advanced molecular assays with cloud-enabled data analytics for real-time disease, pathogen and contaminant detection.